Industry News
DSMB clears Alchemia to continue cancer trial
The DSMB overseeing Alchemia's phase III trial of HA-Irinotecan in metastatic colorectal cancer has recommended the trial continue on the strength of existing safety data. [ + ]
IND lodged for Bionomics anxiety compound
Bionomics (ASX:BNO) US partner, Ironwood Pharmaceuticals, has lodged an Investigational New Drug application with the US FDA for anti-anxiety compound IW-2143 and has the go-ahead to conduct a phase I trial. [ + ]
Great Barrier Reef focus of international genome sequencing project
The Sea-quence project will study how corals respond to climate change, gathering the genomes of corals in the Great Barrier Reef and the Red Sea. [ + ]
Australian biotech looking ‘healthy’ as it gathers for AusBiotech 2012
The AusBiotech 2012 national conference has again showcased the great talent and intellectual capital within Australia’s biotechnology industry. [ + ]
Gene find turns soldier beetle defence into biotech opportunity
New antibiotic and anticancer chemicals may one day be synthesised using biotechnology, following CSIRO’s discovery of the three genes that combine to provide soldier beetles with their potent predator defence system. [ + ]
Multispectral imaging research grant program announced
Ocean Thin Films is calling for grant proposals featuring multispectral imaging applications that would utilise the SpectroCam platform. The grant gives participants the opportunity to add a high-end instrument to their lab at little or no cost. [ + ]
Measuring metabolism can predict the progress of Alzheimer’s
When it comes to Alzheimer’s disease, scientists usually look to the brain as their first centre of attention. Now researchers at Tel Aviv University (TAU) say that early clues regarding the progression of the disease can be found in the brain’s metabolism. [ + ]
Senz recruits first patient for leukaemia trial
Senz Oncology has recruited the first subject for the debut human trial of oral chemotherapeutic candidate VAL-1000 in patients with acute leukaemia. [ + ]
Predicting cancer: it’s all in the numbers
Australian researchers have developed a statistical model that will help identify people with a high risk of bowel and endometrial cancer. [ + ]
Biota reaps $4.2m from R&D Tax Incentive
Biota (ASX:BTA) will add a $4.2m tax credit for the December quarter to its bottom line after receiving the funds through the R&D Tax Incentive. [ + ]
Major award for global climate change scientist
The ability of a world-renowned ocean scientist to inform the media and the wider community about his work has won him a prestigious international award. [ + ]
Bioniche partner pulls plug on Urocidin trial
Bioniche (ASX:BNC) said its licensing partner has called off a phase III trial of Urocidin, a bladder cancer treatment, due in part to slow recruitment. [ + ]
CSL trials new heart attack treatment
Data from early studies of CSL's (ASX:CSL) lipoprotein-based treatment candidate show its potential in reducing the risk of recurrent heart attacks. [ + ]
Australian colorectal cancer blood test attracts attention from US
Quest Diagnostics is evaluating using a biomarker-based blood test for colorectal cancer developed by Clinical Genomics, the CSIRO and the Flinders Centre for Innovation in Cancer. [ + ]
Monash team wins grant for inhalable oxytocin
A Monash University team has won a $1 million grant to develop an inhalable oxytocin treatment for post-partum haemorrhage, a leading cause of death in emerging markets. [ + ]
